The POLA1 gene helps cells start copying DNA before they divide. When it does not work properly, cells may struggle to grow and repair normally, which can affect the skin, immune system, and development. The protein made by this gene helps your cells make the short starter pieces needed for DNA copying. Harmful variants in the POLA1 gene are linked to rare inherited conditions, including X linked reticulate pigmentary disorder and some forms of developmental delay.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing activities in the body. Some genes carry the code for proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can shape how you respond to food, stress, or medications. You can find more detail on this topic in the LearnHub.
Overview
POLA1Gene function
What if the gene works
The POLA1 gene helps cells start copying DNA before they divide. Its protein makes a short starter piece that lets other cell proteins continue building the new DNA strand.
Risk
What if the gene does not work
Variants in the POLA1 gene can cause patterned skin pigmentation with repeated infections and bowel inflammation, or developmental conditions with growth delay and intellectual disability. Milder and more severe variants may change which features appear and how strongly.
Treatment
What does that mean for your treatment
No POLA1-specific treatment or drug selection approach is currently established in clinical guidelines; care is based on the person’s symptoms and complications. Research is exploring whether abnormal interferon signaling in some POLA1-related conditions could help guide future targeted treatments, but this is not yet standard care.
Conditions associated with POLA1
Gene function
What if the gene works
Each time your body makes a new cell, it must copy its DNA accurately. The POLA1 gene supports the first step of that copying process, so cells can begin building a full new DNA strand. Understanding POLA1 gene function helps explain how cells prepare for normal growth, repair, and everyday tissue renewal.
Inside your cells, the POLA1 gene helps start the process of copying DNA before a cell divides. It makes the first short stretch that lets other DNA copying proteins continue the job.
The POLA1 gene works with partner proteins to build tiny starter pieces made of RNA and DNA. These short starters act like launch pads that allow DNA copying to move forward.
This activity helps cells duplicate their genetic material in an organized way before they split into two new cells. It supports everyday tissue renewal across the body, such as in the skin, blood, and gut lining.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help make up normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the POLA1 gene can reduce how much POLA1 protein a cell makes or change its shape so it works less well. Some POLA1 gene variants alter splicing (how the RNA message is pieced together), while more severe variants can sharply cut protein production or leave the protein largely nonworking. This range helps explain how POLA1 gene variants affect function, from partial loss to near-complete loss, and may influence how early or how strongly POLA1-related features appear.
How variants are linked to conditions
Conditions linked to the POLA1 gene variants most clearly include X linked reticulate pigmentary disorder, a rare inherited condition that can cause net-like darker skin changes, repeated infections, and often eye, lung, or digestive inflammation. Other rare, more disruptive changes in the POLA1 gene have also been linked to an X linked developmental condition that may include poor growth, small head size, hearing loss, and intellectual disability.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural variation among people. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the POLA1 gene. Risk is mainly linked to whether someone carries a disease-causing change in this gene and, in families, how that change is inherited. Anyone concerned about personal or family risk can speak with a doctor or genetic counselor.
Inheritance of POLA1 variants
The POLA1 gene inheritance pattern depends on the specific POLA1-related condition. Because the POLA1 gene is on the X chromosome, established POLA1-related conditions follow X-linked inheritance. In families, a mother carrying a disease-causing variant can pass it to sons or daughters, while an affected father passes his X chromosome to all daughters and to none of his sons. Some POLA1-related conditions are described as X-linked recessive, while the reticulate pigmentary condition linked to the POLA1 gene has a distinct X-linked pattern that mainly affects males.
What does my POLA1 result mean for my family?
POLA1-related conditions are usually inherited through the X chromosome, and what this means for family members depends on the exact POLA1 change and the condition linked to it. In some families, male relatives may be more likely to have symptoms, while female relatives may be carriers or may have milder features. Close relatives on the same side of the family may share the variant, so the result can be relevant beyond just one person.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the POLA1 gene, doctors use POLA1 genetic testing on a blood sample, saliva, or cheek swab. A lab reads the gene’s DNA code and compares it with the usual sequence to identify variants, which can help confirm or rule out a suspected inherited condition.
When should I consider getting a genetic test?
Testing for the POLA1 gene may be worth considering if there is a family history of a rare POLA1-related condition, especially when several boys or men are affected. It can also help explain a pattern of unusual skin coloring, frequent infections, and developmental concerns when these features occur together.
A genetic result is only one part of your health story
Genetic results can provide useful information, but what they can tell you varies with the condition and the kind of variant that is present. Over time, the body is shaped by many factors, including lifestyle, environment, age, and medical history. For some health conditions, especially ones affected by many genes, genetic information offers added context rather than certainty and makes the most sense when considered with the rest of a person’s care. In other situations, a genetic finding can give a more definite answer. In areas like medication response, these results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. This helps explain why the same treatment works well for one person, has little effect in another, or causes more side effects in someone else. Differences in how the body breaks down, moves, or responds to a drug are common and can influence both benefit and sensitivity to treatment.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support more informed and more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the POLA1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so questions about medicines, side effects, or changes in your health are best discussed with your doctor.
History
POLA1 entered genetics through basic research on how cells copy DNA, with key enzyme activity described in the late 1960s and 1970s. In the 1980s, researchers identified and mapped the human POLA1 gene, which helped connect earlier laboratory findings to a specific gene in people. From these first observations, research expanded steadily. Much later, rare inherited POLA1 variants were linked to human conditions, including an X linked pigmentary condition first recognized through distinctive skin changes and recurrent infections. That shift from laboratory discovery to clinical genetics made POLA1 part of a broader story about how genes first studied in cell biology can later help explain inherited disease.